- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02600884
Efficacy Trial of a Brief Parent-Based Adolescent Sexual Health Intervention
October 31, 2023 updated by: Diane Santa Maria, The University of Texas Health Science Center, Houston
The purpose of this research study is to evaluate a brief parent-based adolescent sexual health intervention called Families Talking Together Plus (FTT+).
FTT+ is based on an established intervention called Families Talking Together (FTT) and will enhance FTT by adding modules on human papillomavirus (HPV).
The goal of the study is to evaluate whether FTT will help parents increase sexual health communication, delay adolescent sexual debut, and increase HPV vaccination.
FTT will be delivered to parents of minority youth and will be delivered by student nurses.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
1183
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77030
- The University of Texas Health Science Center at Houston
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
11 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Age limit for parents: minimum = N/A (No limit); maximum = N/A (No limit) Age limit for children: minimum = 11 years; maximum = 14 years
Inclusion Criteria:
- Parent: resides with a child 11-14 years old who attends a participating community center, after-school program, or Boys and Girls Club (BGC)
- Parent: available for a face-to-face or small group session with the PI or student nurse within 2 months of consenting and assenting to participate in the study
- Parent: can read, write, and speak English or Spanish
- Child: between 11-14 years of age
Exclusion Criteria:
- Parent: Without primary custody of child
- Parent: Incarcerated
- Parent: Unable to attend a face-to-face session within 2 months
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Families Talking Together Plus (FTT+HPV)
Parents in the experimental group will attend a 1-hour intervention session, receive program materials to use with youth at home, and receive 2 booster phone calls post-intervention.
Content of the experimental intervention includes parent-child sexual health communication and HPV vaccination navigation.
|
Intervention parents will attend a 1-hour intervention session and receive program materials to use with youth at home and 2 booster phone calls post intervention.
Content of the experimental intervention includes parent child sexual health communication and HPV vaccination navigation.
|
|
Active Comparator: Brief motivational interviewing (BMI)
Parents in the brief motivational interviewing (BMI) group will attend a 1-hour intervention session, receive program materials to use with youth at home, and receive 2 booster phone calls post-intervention.
Content of the control intervention includes obesity prevention strategies using motivational interviewing.
|
Control parents will attend a 1-hour intervention session and receive program materials to use with youth at home and 2 booster phone calls post intervention.
Content of the control intervention includes obesity prevention strategies using motivational interviewing.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in parent child communication as assessed by the Families Talking Together Plus HPV (FTT + HPV) survey administered to parents
Time Frame: 1 month
|
The FTT + HPV survey is a survey that has been developed by the investigator for this study.
The survey is administered at baseline, 1, and 6 months using iPads and is available as Audio Computer-Assisted Self-Interviews in both English and Spanish.
|
1 month
|
|
Change in parent child communication as assessed by the FTT + HPV survey administered to parents
Time Frame: 6 months
|
6 months
|
|
|
Change in intentions for sex as assessed by the FTT + HPV survey administered to youths
Time Frame: 1 month
|
1 month
|
|
|
Change in intentions for sex as assessed by the FTT + HPV survey administered to youths
Time Frame: 6 months
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in parental monitoring as assessed by the FTT + HPV survey administered to parents
Time Frame: 1 month
|
1 month
|
|
Change in parental monitoring as assessed by the FTT + HPV survey administered to parents
Time Frame: 6 months
|
6 months
|
|
Change in parental involvement as Assessed by the FTT + HPV survey administered to parents
Time Frame: 1 month
|
1 month
|
|
Change in parental involvement as assessed by the FTT + HPV survey administered to parents
Time Frame: 6 months
|
6 months
|
|
Change in intentions for communication as assessed by the FTT + HPV survey administered to parents
Time Frame: 1 month
|
1 month
|
|
Change in intentions for communication as assessed by the FTT + HPV survey administered to parents
Time Frame: 6 months
|
6 months
|
|
Change in intentions for HPV vaccination of child as assessed by the FTT + HPV survey administered to parents
Time Frame: 1 month
|
1 month
|
|
Change in intentions for HPV vaccination of child as assessed by the FTT + HPV survey administered to parents
Time Frame: 6 months
|
6 months
|
|
Change in sexual activity as assessed by the FTT + HPV survey administered to youths
Time Frame: 1 month
|
1 month
|
|
Change in sexual activity as assessed by the FTT + HPV survey administered to youths
Time Frame: 6 months
|
6 months
|
|
Change in knowledge of HPV risk factors as assessed by the FTT + HPV survey administered to youths
Time Frame: 1 month
|
1 month
|
|
Change in knowledge of HPV risk factors as assessed by the FTT + HPV survey administered to youths
Time Frame: 6 months
|
6 months
|
|
Change in parental communication as assessed by the FTT + HPV survey administered to youths
Time Frame: 1 month
|
1 month
|
|
Change in parental communication as assessed by the FTT + HPV survey administered to youths
Time Frame: 6 months
|
6 months
|
|
Change in HPV vaccine received as assessed by the FTT + HPV survey administered to youths
Time Frame: 1 month
|
1 month
|
|
Change in HPV vaccine received as assessed by the FTT + HPV survey administered to youths
Time Frame: 6 months
|
6 months
|
Other Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in confidence as sex educators as assessed by the FTT + HPV survey administered to student nurses
Time Frame: 1 month
|
1 month
|
|
Change in confidence as sex educators as assessed by the FTT + HPV survey administered to student nurses
Time Frame: 6 months
|
6 months
|
|
Change in intentions to endorse HPV vaccination as assessed by the FTT + HPV survey administered to student nurses
Time Frame: 1 month
|
1 month
|
|
Change in intentions to endorse HPV vaccination as assessed by the FTT + HPV survey administered to student nurses
Time Frame: 6 months
|
6 months
|
|
Change in knowledge of HPV risk factors as assessed by the FTT + HPV survey administered to student nurses
Time Frame: 1 month
|
1 month
|
|
Change in knowledge of HPV risk factors as assessed by the FTT + HPV survey administered to student nurses
Time Frame: 6 months
|
6 months
|
|
Change in beliefs as assessed by the FTT + HPV survey administered to student nurses
Time Frame: 1 month
|
1 month
|
|
Change in beliefs as assessed by the FTT + HPV survey administered to student nurses
Time Frame: 6 months
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Diane Santa Maria, DrPH, The University of Texas Health Science Center, Houston
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 1, 2015
Primary Completion (Actual)
November 1, 2018
Study Completion (Actual)
April 1, 2019
Study Registration Dates
First Submitted
November 5, 2015
First Submitted That Met QC Criteria
November 5, 2015
First Posted (Estimated)
November 9, 2015
Study Record Updates
Last Update Posted (Actual)
November 3, 2023
Last Update Submitted That Met QC Criteria
October 31, 2023
Last Verified
October 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- HSC-SN-15-0091
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Increase HPV Vaccination Uptake
-
University of RochesterCenters for Disease Control and PreventionCompletedIncrease in Use of Immunization Registry | Increase in HPV Vaccination RateUnited States
-
University of UtahNational Cancer Institute (NCI); Kaiser Permanente; University of Arizona; Sea...CompletedHPV Vaccination | Vaccine; Uptake | Vaccination; Series CompletionUnited States
-
Fondazione Policlinico Universitario Agostino Gemelli...Recruiting
-
Duke UniversityCompletedVaccination UptakeTanzania
-
Xiamen UniversityXiamen Center for Disease Control and PreventionNot yet recruitingHPV Vaccination Rates | HPV Vaccine Awareness | HPV Vaccination Intention
-
Xiamen UniversityXiamen Innovax Biotech Co., Ltd; Xiamen Center for Disease Control and PreventionNot yet recruitingHPV Vaccination Rates | HPV Vaccine Awareness | HPV Vaccination Intention
-
Michigan State UniversityRecruitingHPV VaccinationUnited States
-
Anne E RayReal Prevention, LLC; Merck Institute for Therapeutic ResearchNot yet recruiting
-
Memorial Sloan Kettering Cancer CenterHackensack Meridian Health; The City College of New YorkActive, not recruitingHPV VaccinationUnited States
Clinical Trials on Families Talking Together Plus (FTT+HPV)
-
Johns Hopkins UniversityCompletedBehavior and Behavior MechanismsUnited States
-
Power to DecideNew York University; Healthy Futures of Texas; Rio Grande Valley CouncilCompletedSexual Risk Behavior
-
University of MiamiNational Institute on Minority Health and Health Disparities (NIMHD)CompletedHIV/AIDS | Substance Abuse | Domestic ViolenceUnited States
-
New York UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedBehavior and Behavior MechanismsUnited States
-
Columbia UniversityNational Institute of Mental Health (NIMH)CompletedBehavior and Behavior MechanismsUnited States